These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 3455678

  • 1. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 2. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT, Cirtain MC, Lefko JL.
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM.
    Cancer Res; 1987 Oct 15; 47(20):5455-60. PubMed ID: 2888532
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase.
    Beck WT, Cirtain MC.
    Cancer Res; 1982 Jan 15; 42(1):184-9. PubMed ID: 7198507
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
    Conter V, Beck WT.
    Cancer Treat Rep; 1984 Jun 15; 68(6):831-9. PubMed ID: 6539648
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell lines.
    Beck WT, Danks MK, Cirtain MC, van Heiningen JN.
    Prog Clin Biol Res; 1986 Jun 15; 223():3-10. PubMed ID: 3468517
    [Abstract] [Full Text] [Related]

  • 13. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
    Warren L, Jardillier JC, Ordentlich P.
    Cancer Res; 1991 Apr 15; 51(8):1996-2001. PubMed ID: 1672622
    [Abstract] [Full Text] [Related]

  • 14. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
    Zamora JM, Pearce HL, Beck WT.
    Mol Pharmacol; 1988 Apr 15; 33(4):454-62. PubMed ID: 3162758
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells.
    Danks MK, Metzger DW, Ashmun RA, Beck WT.
    Cancer Res; 1985 Jul 15; 45(7):3220-4. PubMed ID: 3891080
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
    Berlion M, Arvelo F, Leonce S, Bourgeois Y, Rigaudy P, Bizzari JP, Poupon MF.
    In Vivo; 1993 Jul 15; 7(5):399-405. PubMed ID: 7906553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.